2023 Review

2023 Review

Key Indicators
Index / Fund / Rate
Start of 2023
End of 2023
% Change YTD
Index / Fund / Rate
Start of Year
141.43
End of 2023​
188.33
% Change YTD
33.16% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
End of 2023​
76 893 Lunar Capital increasesymbol
% Change YTD
5.26% Lunar Capital increasesymbol
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
End of 2023​​
15 011 Lunar Capital increasesymbol
% Change YTD
43.42% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
End of 2023​
4 770 Lunar Capital increasesymbol
% Change YTD
24.21% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
End of 2023​
11.75% Lunar Capital increasesymbol
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
End of 2023​
18.30 Lunar Capital increasesymbol
% Change YTD
7.77% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
End of 2023​
20.17 Lunar Capital increasesymbol
% Change YTD
9.38% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
End of 2023​
76.97 Lunar Capital increasesymbol
% Change YTD
-10.45% Lunar Capital stocktake arrow down
Source: Iress

Compliments of the season to everyone. We wish you all the best for the year.

Above is a table showing the change in value of some of the key indicators that we have tracked during the year. We were extremely pleased with the 33% increase the Lunar BCI WW Flexible Fund achieved during 2023.

At Lunar Capital, we aim to invest in great businesses that can benefit from long term macro trends. Below are a few examples of long term trends we held last year and I mention some of the holdings we had that resulted in our performance.

1) Technology Innovation

As technology continues to advance, businesses are discovering innovative ways to harness faster and more efficient technologies. This can be done through the development of new products or the enhancement of operational efficiency, leading to cost reduction. Companies like Nvidia and ASML have been relentlessly pursuing new methods to create more efficient semiconductors and the equipment necessary for semiconductor production. These semiconductors provide the foundational building blocks for training Large Language Models, a branch of Artificial Intelligence (AI) that will have many opportunities for businesses to provide AI based services.

2) Cybersecurity

The world’s increasing digitization and interconnectivity to the internet have brought a heightened risk of cyber-attacks. Similarly, the increase in geopolitical tensions also increases the risk of cyberattacks. Consequently, there is a growing demand for enhanced cybersecurity measures from individuals, businesses, and governments. Companies like Palo Alto and Crowdstrike are at the forefront of developing new online security tools. Crowdstrike notably uses AI to detect and prevent cyberattacks.

3) Aging Populations and Modern Diseases

In developed nations, the average life expectancy is on the rise, leading to an increased demand for medical care as individuals live longer. This demographic shift also amplifies the need for effective wealth management, particularly among the wealthier older generations. UBS, a Swiss banker and wealth manager has benefited significantly in managing money for its wealthy clients around the world.

Companies such as Novo Nordisk and Eli Lilly have played a pivotal role in addressing health concerns associated with obesity, which is prevalent around the world . A recent trial showed that Novo Nordisk’s Semaglutide reduces the risk of major adverse cardiovascular events by 20% in adults who suffer from obesity.

Our view is that these themes can play out over multiple years. At Lunar Capital, we aim to find great businesses that we think will do well with the tailwinds from these mega-trends. Sabir covers this in more depth in his Quarterly Investment Review and Investment Strategy.

Nvidia, ASML, Microsoft, Palo Alto, Crowdstrike, UBS, Novo Nordisk and Eli Lilly are held in the Lunar BCI Worldwide Flexible fund. They are also held by Lunar Capital’s Offshore Portfolio clients.

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Share article

Latest Posts

Nvidia: Fear of Missing Out
Nvidia – Fear of Missing Out
What questions are we asking about AI and Nvidia
ON Top of It
ON Top of It
Rodger Federer, growing revenues, and expanding margins. Let’s dive into sports apparel brand ON’s recent success.
Novo – Lilly: Building Capacity
Novo – Lilly: Building Capacity
Find out how Eli Lilly and Novo Nordisk have been dealing with the demand for their obesity drugs.

Lunar Capital
on Eastwave Radio

Every Wednesday, at 07h45, Sabir chats with Nazia from Eastwave Radio (92.2 fm, live stream on
www.eastwave.co.za) on investing and the markets.

eastwave-radio
Scroll to Top